Keith Krehbiel, diagnosed with early-onset Parkinson's disease, suffered debilitating symptoms until a 2020 surgery. The deep-brain stimulation technology, which adjusts stimulation based on brain signals, transformed his life. Krehbiel significantly reduced his medication and eliminated unpleasant symptoms like tremors, nausea, and dyskinesia. His case became a pivotal part of a clinical trial that led to FDA approval for this innovative treatment, marking a significant advancement for the millions living with Parkinson's disease globally.
Krehbiel was the first participant to enroll in a clinical trial testing a new form of deep-brain stimulation, which dramatically improved his Parkinson's symptoms.
After the surgery in 2020, Krehbiel reported a substantial reduction in his medications and a remarkable improvement in his quality of life.
Collection
[
|
...
]